- Home
- EAST vs SONN Comparison
EAST vs SONN Comparison
Compare EAST & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EAST
- SONN
- Stock Information
- Founded
- EAST 2008
- SONN N/A
- Country
- EAST United States
- SONN United States
- Employees
- EAST N/A
- SONN N/A
- Industry
- EAST Beverages (Production/Distribution)
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- EAST Consumer Staples
- SONN Health Care
- Exchange
- EAST Nasdaq
- SONN Nasdaq
- Market Cap
- EAST 2.8M
- SONN 2.5M
- IPO Year
- EAST N/A
- SONN N/A
- Fundamental
- Price
- EAST $0.73
- SONN $1.54
- Analyst Decision
- EAST Strong Buy
- SONN Strong Buy
- Analyst Count
- EAST 1
- SONN 2
- Target Price
- EAST $3.50
- SONN $38.00
- AVG Volume (30 Days)
- EAST 174.6K
- SONN 267.1K
- Earning Date
- EAST 11-14-2024
- SONN 02-12-2025
- Dividend Yield
- EAST N/A
- SONN N/A
- EPS Growth
- EAST N/A
- SONN N/A
- EPS
- EAST N/A
- SONN N/A
- Revenue
- EAST $9,537,000.00
- SONN $18,626.00
- Revenue This Year
- EAST $231.61
- SONN N/A
- Revenue Next Year
- EAST $73.48
- SONN N/A
- P/E Ratio
- EAST N/A
- SONN N/A
- Revenue Growth
- EAST 81.73
- SONN N/A
- 52 Week Low
- EAST $0.41
- SONN $1.41
- 52 Week High
- EAST $2.98
- SONN $18.72
- Technical
- Relative Strength Index (RSI)
- EAST 45.86
- SONN 36.95
- Support Level
- EAST $0.70
- SONN $1.46
- Resistance Level
- EAST $0.91
- SONN $2.52
- Average True Range (ATR)
- EAST 0.10
- SONN 0.18
- MACD
- EAST -0.02
- SONN 0.06
- Stochastic Oscillator
- EAST 11.72
- SONN 9.26
About EAST Eastside Distilling Inc.
Eastside Distilling Inc is a producer and marketer of Craft Canning and Printing and Spirits. Its alcoholic beverage categories include whiskey, vodka, gin, rum, tequila, and Ready-to-Drink. Some of its brands include Azunia Tequila, Hue-Hue Coffee Rum, Portland Potato Vodka, and Burnside Whiskey. It operates in two segments of packaging, producing, marketing, and distributing alcoholic beverages. Craft Canning + Printing includes Digital Can Printing, Co-packing Facility, and Mobile Canning. The company distributes its products in 33 states of the United States.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.